These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36650624)

  • 1. Impacts of Plant-derived Secondary Metabolites for Improving Flora in Type 2 Diabetes.
    Li LZ; Yan Y; Song Q; Wang Z; Zhang W; Hou Y; Zhang X
    Curr Diabetes Rev; 2023; 19(7):e160123212750. PubMed ID: 36650624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus.
    He L; Yang FQ; Tang P; Gao TH; Yang CX; Tan L; Yue P; Hua YN; Liu SJ; Guo JL
    Biomed Pharmacother; 2022 Jul; 151():113091. PubMed ID: 35576662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research progress in the relationship between type 2 diabetes mellitus and intestinal flora.
    Ma Q; Li Y; Li P; Wang M; Wang J; Tang Z; Wang T; Luo L; Wang C; Wang T; Zhao B
    Biomed Pharmacother; 2019 Sep; 117():109138. PubMed ID: 31247468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of probiotics on glycemic control and intestinal dominant flora in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis.
    Sun Y; Huang Y; Ye F; Liu W; Jin X; Lin K; Wang J; Gao Y; He L
    Medicine (Baltimore); 2020 Nov; 99(46):e23039. PubMed ID: 33181668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will intestinal flora therapy become a new target in type-2 diabetes mellitus? A review based on 13 clinical trials.
    Wang F; Zhao T; Wang W; Dai Q; Ma X
    Nutr Hosp; 2022 Mar; 39(2):425-433. PubMed ID: 34844413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol extract of propolis regulates type 2 diabetes in mice via metabolism and gut microbiota.
    Guan R; Ma N; Liu G; Wu Q; Su S; Wang J; Geng Y
    J Ethnopharmacol; 2023 Jun; 310():116385. PubMed ID: 36931413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between intestinal flora and human iron metabolism: the role in metabolic syndrome-related comorbidities and its potential clinical application.
    Yan Y; Zhang W; Wang Y; Yi C; Yu B; Pang X; Li K; Li H; Dai Y
    Microbiol Res; 2024 May; 282():127667. PubMed ID: 38442456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota: A new target for T2DM prevention and treatment.
    Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-Derived Bioactive Compounds and Potential Health Benefits: Involvement of the Gut Microbiota and Its Metabolic Activity.
    Chen X; Pan S; Li F; Xu X; Xing H
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites.
    Zhang X; Wang H; Xie C; Hu Z; Zhang Y; Peng S; He Y; Kang J; Gao H; Yuan H; Liu Y; Fan G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123189. PubMed ID: 35219959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolites of Gut Microbiota and Possible Implication in Development of Diabetes Mellitus.
    Guo Z; Pan J; Zhu H; Chen ZY
    J Agric Food Chem; 2022 May; 70(20):5945-5960. PubMed ID: 35549332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice.
    Horie M; Miura T; Hirakata S; Hosoyama A; Sugino S; Umeno A; Murotomi K; Yoshida Y; Koike T
    Exp Anim; 2017 Oct; 66(4):405-416. PubMed ID: 28701620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gut microbiota is a factor of risk for obesity and type 2 diabetes].
    Demidova TY; Lobanova KG; Oinotkinova OS
    Ter Arkh; 2020 Nov; 92(10):97-104. PubMed ID: 33346486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress in the treatment of an immune system disease-type 1 diabetes-by regulating the intestinal flora with Chinese medicine and food homologous drugs.
    Ping Y; Liu J; Wang H; Wang Y; Qiu H; Zhang Y
    Biosci Microbiota Food Health; 2024; 43(3):150-161. PubMed ID: 38966054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.
    Song Z; Yan A; Guo Z; Zhang Y; Wen T; Li Z; Yang Z; Chen R; Wang Y
    Front Cell Infect Microbiol; 2023; 13():1218326. PubMed ID: 37600949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Glucan attenuates cognitive impairment of APP/PS1 mice via regulating intestinal flora and its metabolites.
    Zhang Q; Zhao W; Hou Y; Song X; Yu H; Tan J; Zhou Y; Zhang HT
    CNS Neurosci Ther; 2023 Jun; 29(6):1690-1704. PubMed ID: 36890624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota: a new avenue to reveal pathological mechanisms of constipation.
    Yang L; Wang Y; Zhang Y; Li W; Jiang S; Qian D; Duan J
    Appl Microbiol Biotechnol; 2022 Nov; 106(21):6899-6913. PubMed ID: 36190540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment strategies for type 2 diabetes based on regulating intestinal flora.
    Xie D; Zhao X; Chen M
    Biosci Trends; 2021 Nov; 15(5):313-320. PubMed ID: 34565781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.